Tesamorelin therapy reduces visceral adipose tissue in HIV lipodystrophy

Tesamorelin therapy reduces visceral adipose tissue in HIV lipodystrophy

New England Journal of Medicine

2010

Study summary

Tesamorelin was studied in patients with HIV-associated lipodystrophy.

Peptides studied

Stack studied

GH Optimization Stack

Key findings

Significant reduction in visceral adipose tissue and increase in IGF-1 levels observed.

Study details

Study type

randomized clinical trial

Journal

New England Journal of Medicine

DOI / PubMed

10.1056/NEJMoa0911289

Year

2010

Explore peptide profiles

Discover compounds, understand their mechanisms, and explore the research behind each peptide.

Explore the science. Follow the connections.

Start with a peptide, a goal, a mechanism, or a study. Discover how every piece of research connects across the platform.

Search peptides, goals, studies,...

Research made connected. Build for curious minds.

© 2026 All rights reserved

This platform is for informational and research purposes only. It does not provide medical advice. Always consult a qualified healthcare provider.

Explore the science. Follow the connections.

Start with a peptide, a goal, a mechanism, or a study. Discover how every piece of research connects across the platform.

Search peptides, goals, studies,...

Research made connected. Build for curious minds.

© 2026 All rights reserved

This platform is for informational and research purposes only. It does not provide medical advice. Always consult a qualified healthcare provider.

Explore the science. Follow the connections.

Start with a peptide, a goal, a mechanism, or a study. Discover how every piece of research connects across the platform.

Search peptides, goals, studies,...

Research made connected. Build for curious minds.

© 2026 All rights reserved

This platform is for informational and research purposes only. It does not provide medical advice. Always consult a qualified healthcare provider.